Breast Cancer Research volume 10, Article number: S1 (2008) Cite this article 11k Accesses 7 Altmetric Metrics details Abstract Immunocytochemical or molecular assays allow the detection of single disseminated tumor cells (DTCs) in the bone marrow (BM) or the peripheral blood in 10% to 60% of...
priorities in researchpriority settingBreast cancer remains the most common cancer among women, and the second most common cause of cancer death. With advances in treatment, women are living longer, in some cases many years, with metastatic breast cancer (MBC). These advances are a direct result...
Chapters and Articles You might find these chapters and articles relevant to this topic. Cancer neoantigen: Boosting immunotherapy PeijiaXu, ...XiaoZhu, inBiomedicine & Pharmacotherapy, 2020 3.5Metastatic breast cancer Breast cancer is an epithelial cancer with a low level ofsomatic mutation, ...
Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach tha
Anderson (Olivia Newton-John Cancer Research Institute) for donating E0771.lmb mouse breast cancer cells; the Genomics Facility Basel (D-BSSE of the ETH Zurich) for generating libraries and carrying out next-generation sequencing; P. Lorentz (University of Basel) for microscopy support; A. ...
Despite the significant advances in breast cancer biology, there has been limited progress in the treatment of advanced breast cancer, with little change in the overall survival for women with metastatic breast cancer over the last sever... MD Landis,LA Burey,JC Chang - 《Cancer Research》 被引...
The DESTINY-Breast06 trial investigated earlier and broader use of trastuzumab deruxtecan in patients with metastatic hormone-receptor-positive breast cancer, and demonstrated improvements in progression-free survival over standard chemotherapy. These da
Many patients with metastatic breast cancer receive several types of chemotherapy, although it is recognized that there is a declining probability of respo
This page is a summary of: Lung Cancer Metastatic to Breast, Ultrasound Quarterly, September 2013, Wolters Kluwer Health, DOI: 10.1097/ruq.0b013e3182a00fc4. You can read the full text:Read Contributors The following have contributed to this page RBSorry, your browser does not support inline...
We further explored cell line MDA-MB-231, one of the most widely used triple-negative cell lines in metastatic breast cancer research. We ranked all of the 1019 CCLE cell lines according to their transcriptome similarity with Basal-like MET500 breast cancer samples and the rank of MDA-MB-231...